Medical device company Biovo Technologies Ltd revealed on Thursday that it has commissioned its Cuffix devices in the largest newly established COVID-19 ward in one of Israel's leading hospitals, with a capacity of 170 ventilated patients.
The company added that Cuffix is the first and only economical, self-contained, disposable cuff pressure regulator and monitor in the market.
As ICUs are full and medical personnel is stretched to the limit, the single use products including Cuffix can assist with treating COVID-19 patients and reduce nurse work load. This has dramatically increased worldwide interest in Biovo's products.
Under the company's plan to increase sales and production volumes, it has signed distribution agreements in Australia and Brazil and following the recent 510K FDA clearance, the next commercialization step is in the USA and discussions are already underway.
Crossject advances paediatric development of ZEPIZURE Junior for epilepsy crisis management
Creo Medical secures FDA clearance for SpydrBlade Flex in US market
Tissue Regenix secures CE and UKCA certifications for OrthoPure XT
Terumo Corporation expands stroke portfolio in EMEA with SOFIA Flow 88 catheter launch
Crossject advances ZENEO manufacturing with scalable aseptic filling module ahead of product rollout
ZYLOX Unicorn Vascular Closure Device approved in Indonesia
Mindray unveils BeneVision V Series at Euroanaesthesia 2025, advancing precision monitoring
Unicon Pharma and VRR Life Sciences partner support digital transformation in life sciences
Median Technologies submits 510(k) application for eyonis LCS lung cancer screening software